A Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)
Bristol-Myers Squibb
Bristol-Myers Squibb
Autolus Limited
SymBio Pharmaceuticals
M.D. Anderson Cancer Center
Fondazione Italiana Linfomi - ETS
City of Hope Medical Center